Literature DB >> 10454024

Micrometastasis in oral/oropharyngeal squamous cell carcinoma: incidence, histopathological features and clinical implications.

J A Woolgar1.   

Abstract

The prognostic importance of accurate pathological staging of oral cancer patients with established lymph node metastases is well known. The present study sought to determine the incidence and clinical significance of minimal neck disease (only micrometastases) and to evaluate clinical features of the primary tumour in relation to the pathological metastatic status. Surgical resection specimens from 178 patients with oral/oropharyngeal squamous cell carcinoma were assessed by routine techniques. Micrometastases were defined as intranodal deposits measuring in total no more than 3 mm at any level of sectioning. Fourteen patients (8%) had only micrometastases and 72 (40%) had established nodal metastases. Patients with only micrometastases were younger than those with established metastases, but there were no differences in T site, T stage or sex. The outcome (2-6 years postsurgery) of patients with only micrometastases was similar to those without cervical node metastases. Hence, the main short-term significance of micrometastases seems to be in relation to clinical staging and elective management of the NO neck.

Entities:  

Mesh:

Year:  1999        PMID: 10454024     DOI: 10.1054/bjom.1999.0037

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  17 in total

1.  Is there a role for lymphoscintigraphy and sentinel node biopsy in the management of the regional lymphatics in mucosal squamous cell carcinoma of the head and neck?

Authors:  Nicholas Hyde; Elizabeth Prvulovich
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-03-27       Impact factor: 9.236

2.  Detection of bone marrow micrometastases in the rib marrow of head and neck cancer patients: a prospective pilot study.

Authors:  Liam J Skinner; Brendan J Conlon; John D Russell; Gerald C O'sullivan; Tadhg P O'dwyer
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-06-09       Impact factor: 2.503

3.  [Workshop Sentinel Node 2003. November 8, 2003, Marburg].

Authors:  J A Werner
Journal:  HNO       Date:  2004-03       Impact factor: 1.284

Review 4.  Role of sentinel node biopsy in the management and staging of the N0 neck.

Authors:  Gary L Ross; Taimur Shoaib
Journal:  Odontology       Date:  2005-09       Impact factor: 2.634

Review 5.  Surgical management of the N0 neck in early stage T1-2 oral cancer; a personal perspective of early and late impalpable disease.

Authors:  R A Ord
Journal:  Oral Maxillofac Surg       Date:  2012-05-13

6.  Postoperative radiotherapy is dispensable for OSCC patients with micrometastases in lymph nodes.

Authors:  Y M Pu; Y Yang; Y J Wang; L Ding; X F Huang; Z Y Wang; Y H Ni; Q G Hu
Journal:  Virchows Arch       Date:  2018-04-09       Impact factor: 4.064

7.  [Sentinel lymphonodectomy as a staging method for head and neck cancer. Analysis of 70 patients].

Authors:  A F Kovács; H Walendzik; N Döbert; C Menzel
Journal:  HNO       Date:  2005-06       Impact factor: 1.284

8.  Micrometastasis of hypopharyngeal cancer.

Authors:  P Sabljak; P Pesko; D Stojakov; M Micev; E Keramatollah; D Velickovic; O Skrobic; V Sljukic; A Djikic-Rom
Journal:  Langenbecks Arch Surg       Date:  2014-05-11       Impact factor: 3.445

9.  Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma.

Authors:  L W T Alkureishi; Z Burak; J A Alvarez; J Ballinger; A Bilde; A J Britten; L Calabrese; C Chiesa; A Chiti; R de Bree; H W Gray; K Hunter; A F Kovacs; M Lassmann; C R Leemans; G Mamelle; M McGurk; J Mortensen; T Poli; T Shoaib; P Sloan; J A Sorensen; S J Stoeckli; J B Thomsen; G Trifiro; J Werner; G L Ross
Journal:  Ann Surg Oncol       Date:  2009-11       Impact factor: 5.344

10.  Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma.

Authors:  Lee W T Alkureishi; Zeynep Burak; Julio A Alvarez; James Ballinger; Anders Bilde; Alan J Britten; Luca Calabrese; Carlo Chiesa; Arturo Chiti; Remco de Bree; Harry W Gray; Keith Hunter; Adorjan F Kovacs; Michael Lassmann; C Rene Leemans; Gerard Mamelle; Mark McGurk; Jann Mortensen; Tito Poli; Taimur Shoaib; Philip Sloan; Jens A Sorensen; Sandro J Stoeckli; Jorn B Thomsen; Giusepe Trifiro; Jochen Werner; Gary L Ross
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-11       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.